Ypsomed Holding AG

Ypsomed Holding AG

YPHDF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$5.66B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Ypsomed Holding AGYpsomed Holding AG34.11.02%42%4.60.3
$-145.56

Current Fair Value

133.3% downside

Overvalued by 133.3% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$5.66 Billion
Enterprise Value$5.86 Billion
Annual dividend$3.35
Dividend yield1.02%
Earnings per Share$16.31
Beta0.89
Outstanding Shares13,147,596

Return

Return on Equity42.12%ROE
Return on Assets22.50%
Return on Invested Capital35.89%

Valuation & Multiples

P/E Ratio34.1P/E Ratio
PEG-88.54PEG
Price to Sales4.6Price to Sales
Price to Book Ratio7.28Price to Book Ratio
Enterprise Value to Revenue4.64
Enterprise Value to EBIT14.84
Enterprise Value to Net Income17
Total Debt to Enterprise0.04
Debt to Equity0.3Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 11, 2026
EPS
$7.78
Est. $6.25
Revenue
$379.90 M
Est. $375.81 M

Next Earnings Call

Expected Date
May 26, 2027
EPS Estimate
$10.24
Consensus analyst estimate
Revenue Estimate
$457.35 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Ypsomed Holding AG

2,025 employees
CEO: Simon Michel

Ypsomed Holding AG, along with its affiliates, specializes in the design, production, and sale of advanced injection and infusion delivery systems for pharmaceutical and biotechnology enterprises. The company structures its activities in...